Divya joined EyeBio as Senior Vice President of Clinical Development. She is responsible for the company’s clinical development strategy and execution.
Prior to joining EyeBio, Divya held various roles at the United Kingdom’s (UK) National Institute for Health Research (NIHR) beginning in 2007. Her most recent role at NIHR was the Clinical Research Network’s Director of Business Development and Marketing, where she led a team responsible for increasing investment into UK-based health and social care research from both non-commercial and commercial research sponsors.
In 2020, Divya was seconded to the UK Vaccines Taskforce (VTF), which was set up in response to the COVID-19 pandemic to lead the UK’s search for a safe and effective vaccine. In that capacity she was responsible for supporting global pharmaceutical companies’ efforts to rapidly generate the evidence required for marketing authorization of COVID-19 vaccines and played a pivotal role in conceptualizing and developing the National Health Service (NHS) Vaccine Research Registry.
Divya holds a B.Sc. in Psychology from Royal Holloway at the University of London, and was awarded an India academic scholarship to complete a MRes degree at the University of Birmingham, UK.
